Form 4: Repligen Corp Director Madaus Increases Stake with Recent Stock Purchases

Director Martin D Madaus of Repligen Corp [RGEN] reports purchasing additional shares of common stock on June 14, 2024, increasing his beneficial ownership.

Summary

• On June 14, 2024, Martin D Madaus, a director of Repligen Corp [RGEN], purchased 915 shares of common stock at a weighted average price of $124.54.
• He also purchased 700 shares at a weighted average price of $125.46 on the same day.
• Following these transactions, Madaus directly owns 4,613 shares and indirectly owns 11 shares through a spouse's trust.
• The reported transactions were filed with the SEC on Form 4.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director increasing their stake suggests confidence, but it's a routine transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's performance and future expectations within the biotechnology sector.

Stakeholder Impact

• The increased stake of a director may positively influence shareholder confidence.

Key Dates